Theme: The Role of Rosuvastatin in Reducing Portal Hypertension in Cirrhotic Patients Without Complete Response to Beta-Blockers: A Triple-Blind, Placebo-Controlled Randomized Clinical Trial

Date: 12/02/2024
Time: 9:00 AM
Mode: In-Person
Location: SME Gastro Auditorium (4th Floor – HUCFF)